Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.59 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.58 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.58 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.58 |
| ▸ | NT5E | P21589 | 1/20 | 0.56 |
| ▸ | KRAS | P01116 | 4/20 | 0.56 |
| ▸ | PNP | P00491 | 2/20 | 0.54 |
| ▸ | POLG | P54098 | 1/20 | 0.53 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.50 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.49 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.49 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.49 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.49 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.49 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.48 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deoxy Adenosinediphosphate SCHEMBL5827743 | 1.00 | TGM2 (0.63) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL7065119 | 0.99 | TGM2 (0.62) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL25712474 | 0.99 | TGM2 (0.62) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL1913809 | 0.99 | TGM2 (0.62) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL2922052 | 0.93 | POLB (0.61) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL20442307 | 0.93 | POLB (0.61) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL22352187 | 0.91 | TGM2 (0.59) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL5334255 | 0.90 | FUT5 (0.58) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL4380341 | 0.90 | TGM2 (0.51) | TGM2POLBFUT5P2RY2P2RY4 | |
| SCHEMBL23584319 | 0.90 | FUT5 (0.64) | TGM2POLBFUT5P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060252115-A1 | Synthesis and use of anti-reverse mRNA cap analogues | DARZYNKIEWICZ EDWARD | 2006-11-09 | — | — | US | disclosed |
| US-7074596-B2 | Synthesis and use of anti-reverse mRNA cap analogues | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2006-07-11 | — | — | US | disclosed |
| US-20030194759-A1 | Synthesis and use of anti-reverse mRBA cap analogues | DARZYNKIEWICZ, EDWARD (PL) | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252115-A1 | Synthesis and use of anti-reverse mRNA cap analogues | RNGTT, RNMT, CPSF6 | TGM2 2476/4885POLB 228/4885FUT5 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.